A. Samson et al.AACR 2023Download the poster herePoster Presentation
Catégorie : Publication
A randomized phase II trial of TG4001 plus avelumab versus avelumab alone in recurrent/metastatic (R/M) human papilloma virus (HPV)-16 positive anogenital cancers
C. Le Tourneau et al.AACR 2023Download the poster herePoster Presentation
Selection of an optimal anti-PD-L1 single domain antibody format for the vectorization into oncolytic vaccinia virus and the generation of bispecific immunomodulators
JM. Marchand et al.AACR 2023Download the poster herePoster Presentation
TG6050 an oncolytic vaccinia virus armed with interleukin 12 and anti-CTLA4 antibody induces TME remodeling and strong anti-tumoral responses
JB. Marchand et al.AACR 2023Download the poster herePoster Presentation
Extracellular vesicles (EV): mediators of therapeutic vaccination? In vivo and in vitro characterization of EVs generated after infection of human and murine cells with therapeutic poxviruses
L. Walther et al.AACR 2023Download the poster herePoster Presentation
Updated data of biodistribution and activity of oncolytic virus TG6002 after intravenous administration in patients with advanced gastrointestinal carcinomas
V. Moreno et al.ESMO 2022Download the poster herePoster Presentation
Phase 1 studies of personalized neoantigen vaccine TG4050 in ovarian carcinoma (OC) and head and heck carcinoma (HNSCC)
JP Delord, et al.ASCO 2022 Abstract available on the ASCO website – Download the poster here Poster Presentation
Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination
Rodrigo Nalio Ramos, et al. Clinical & Translational Immunology, May 8 2022 – Read the article Publication
Comprehensive preclinical studies of BT-001: an oncolytic vaccinia virus armed with Treg-depleting @CTLA4 and GM-CSF
JB Marchand et al.AACR 2022Read the abstract here – Download the poster herePoster Presentation
Phase I trials of personalized cancer vaccine TG4050 in surgically treated high-risk head and neck squamous cell carcinoma (HNSCC) and relapsing ovarian cancer (OvC) patients
MS Block et al.AACR 2022Read the abstract here – Download the poster herePoster Presentation
